Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (16224) 16224
Publication (1434) 1434
Book Review (241) 241
Book Chapter (127) 127
Book / eBook (114) 114
Newsletter (81) 81
Magazine Article (24) 24
Conference Proceeding (22) 22
Dissertation (17) 17
Newspaper Article (7) 7
Reference (2) 2
Presentation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12291) 12291
index medicus (9988) 9988
female (7437) 7437
cancer (6177) 6177
oncology (6127) 6127
male (5867) 5867
middle aged (5610) 5610
aged (4836) 4836
adult (4071) 4071
prognosis (3617) 3617
carcinoma (3392) 3392
tumors (2996) 2996
metastasis (2849) 2849
animals (2543) 2543
expression (2465) 2465
research (2398) 2398
aged, 80 and over (2290) 2290
analysis (2285) 2285
squamous cell carcinoma (2195) 2195
immunohistochemistry (2160) 2160
breast cancer (2112) 2112
care and treatment (2044) 2044
surgery (2026) 2026
health aspects (1944) 1944
cell line, tumor (1919) 1919
gene expression (1848) 1848
pathology (1817) 1817
apoptosis (1787) 1787
risk factors (1767) 1767
chemotherapy (1759) 1759
survival (1709) 1709
proteins (1684) 1684
development and progression (1660) 1660
neoplasm staging (1600) 1600
genetic aspects (1570) 1570
mice (1456) 1456
carcinoma, squamous cell - pathology (1433) 1433
squamous-cell carcinoma (1410) 1410
medicine & public health (1382) 1382
cell biology (1374) 1374
medical prognosis (1339) 1339
retrospective studies (1328) 1328
mortality (1308) 1308
diagnosis (1307) 1307
skin cancer (1256) 1256
medicine (1234) 1234
gene expression regulation, neoplastic (1167) 1167
dermatology (1155) 1155
treatment outcome (1145) 1145
research article (1133) 1133
breast neoplasms - pathology (1124) 1124
cancer therapies (1108) 1108
survival rate (1086) 1086
article (1032) 1032
breast-cancer (1027) 1027
survival analysis (1019) 1019
cell proliferation (1008) 1008
melanoma (1001) 1001
signal transduction (999) 999
kinases (989) 989
patients (986) 986
studies (974) 974
biochemistry & molecular biology (968) 968
follow-up studies (937) 937
lung cancer (936) 936
mutation (928) 928
risk (912) 912
disease-free survival (892) 892
metastases (892) 892
biomarkers, tumor - metabolism (888) 888
multidisciplinary sciences (882) 882
hepatocellular-carcinoma (878) 878
skin neoplasms - pathology (878) 878
biomarkers (872) 872
kaplan-meier estimate (851) 851
neoplasm invasiveness (844) 844
cancer research (834) 834
adenocarcinoma (795) 795
growth (791) 791
oncology, experimental (791) 791
therapy (788) 788
hepatocellular carcinoma (780) 780
medical research (775) 775
science (773) 773
carcinoma, squamous cell - mortality (766) 766
liver cancer (749) 749
activation (741) 741
cell cycle (737) 737
medicine, research & experimental (737) 737
disease progression (730) 730
epidemiology (724) 724
stem cells (720) 720
colorectal cancer (717) 717
breast neoplasms - mortality (716) 716
genes (715) 715
cells (714) 714
radiotherapy (712) 712
proliferation (706) 706
breast neoplasms - metabolism (692) 692
young adult (686) 686
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (90) 90
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
Gerstein Science - Circulation Desk (3) 3
Online Resources - Online (3) 3
St. Michael's Hospital - Stacks (3) 3
Gerstein Science - Reference (2) 2
Humber River Regional Hospital - Finch Stacks (2) 2
Lakeridge Health Sciences - Oshawa (2) 2
Markham Stouffville Hospital - Stacks (2) 2
St Josephs Health Centre - Stacks (2) 2
UTL at Downsview - May be requested (2) 2
Credit Valley Hospital - Special Collections (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Markham Stouffville Hospital - Storage (1) 1
Mt Sinai Hospital - Pathology (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Hospital Department (1) 1
Trillium Health Centre - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (16433) 16433
German (51) 51
French (26) 26
Spanish (12) 12
Russian (10) 10
Polish (8) 8
Italian (7) 7
Japanese (7) 7
Dutch (4) 4
Arabic (3) 3
Chinese (3) 3
Portuguese (3) 3
Danish (2) 2
Swedish (2) 2
Hebrew (1) 1
Korean (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity
by Wang, Zhu A and Mitrofanova, Antonina and Bergren, Sarah K and Abate-Shen, Cory and Cardiff, Robert D and Califano, Andrea and Shen, Michael M
Nature Cell Biology, ISSN 1465-7392, 03/2013, Volume 15, Issue 3, pp. 274 - 283
A key issue in cancer biology is whether oncogenic transformation of different cell types of origin within an adult tissue gives rise to distinct tumour... 
STEM-CELLS | SUBPOPULATION | SUBTYPES | INITIATION | ARCHITECTURE | IDENTIFICATION | LUMINAL CELLS | TUMORIGENESIS | PROGRESSION | MURINE | CELL BIOLOGY | Prostatic Neoplasms - metabolism | Phosphorylation | Cell Proliferation | Epithelial Cells - metabolism | Oligonucleotide Array Sequence Analysis | Humans | PTEN Phosphohydrolase - physiology | Male | Gene Expression Profiling | Neoplasm Recurrence, Local - mortality | Immunoenzyme Techniques | Prostate - metabolism | Neoplasm Recurrence, Local - pathology | Carcinoma, Basal Cell - mortality | Flow Cytometry | Biomarkers, Tumor - metabolism | Adult | Cell Differentiation | Epithelial Cells - cytology | Real-Time Polymerase Chain Reaction | Genes, Reporter | Prostatic Neoplasms - pathology | Neoplasm Recurrence, Local - metabolism | Mice, Inbred C57BL | RNA, Messenger - genetics | Cells, Cultured | Mice, Transgenic | Survival Rate | Carcinoma, Basal Cell - pathology | Keratin-5 - genetics | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Carcinoma, Basal Cell - metabolism | Prostatic Neoplasms - mortality | Cell Lineage | Animals | Fluorescent Antibody Technique | Prostate - cytology | Keratin-5 - metabolism | Biomarkers, Tumor - genetics | Mice | Cell Transformation, Neoplastic - pathology | Apoptosis | Stem cells | Homeostasis | Physiological aspects | Development and progression | Genetic aspects | Research | Health aspects | Prostate cancer | Risk factors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Surgical excision versus Mohs’ micrographic surgery for basal cell carcinoma of the face: A randomised clinical trial with 10 year follow-up
by van Loo, Eva and Mosterd, Klara and Krekels, Gertruud A.M and Roozeboom, Marieke H and Ostertag, Judith U and Dirksen, Carmen D and Steijlen, Peter M and Neumann, H.A. Martino and Nelemans, Patty J and Kelleners-Smeets, Nicole W.J
European Journal of Cancer, ISSN 0959-8049, 2014, Volume 50, Issue 17, pp. 3011 - 3020
Abstract Background Basal cell carcinoma (BCC) is the most common form of cancer among Caucasians and its incidence continues to rise. Surgical excision (SE)... 
Hematology, Oncology and Palliative Medicine | Surgical excision | Basal cell carcinoma | Facial | Mohs surgery | Randomised controlled trial | 5-YEAR RECURRENCE RATES | ONCOLOGY | Facial Neoplasms - mortality | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Treatment Outcome | Neoplasm Recurrence, Local - etiology | Mohs Surgery - mortality | Carcinoma, Basal Cell - mortality | Carcinoma, Basal Cell - surgery | Mohs Surgery - methods | Aged, 80 and over | Adult | Female | Aged | Facial Neoplasms - surgery
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC
by Sekulic, Aleksandar, MD and Migden, Michael R., MD and Lewis, Karl, MD and Hainsworth, John D., MD and Solomon, James A., MD, PhD and Yoo, Simon, MD and Arron, Sarah T., MD, PhD and Friedlander, Philip A., MD, PhD and Marmur, Ellen, MD and Rudin, Charles M., MD, PhD and Chang, Anne Lynn S., MD and Dirix, Luc, MD, PhD and Hou, Jeannie, MD and Yue, Huibin, PhD and Hauschild, Axel, MD and ERIVANCE BCC Investigators and ERIVANCE BCC investigators
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2015, Volume 72, Issue 6, pp. 1021 - 1026.e8
Background Primary analysis from the pivotal ERIVANCE BCC study resulted in approval of vismodegib, a Hedgehog pathway inhibitor indicated for treatment of... 
Dermatology | vismodegib | locally advanced basal cell carcinoma | metastatic basal cell carcinoma | ERIVANCE BCC study | Hedgehog pathway inhibitor | advanced basal cell carcinoma | INHIBITORS | MUTATIONS | HEDGEHOG-PATHWAY | DERMATOLOGY | Anilides - therapeutic use | Skin Neoplasms - drug therapy | Follow-Up Studies | Humans | Middle Aged | Male | Dose-Response Relationship, Drug | Carcinoma, Basal Cell - mortality | Time Factors | Neoplasm Invasiveness - pathology | Skin Neoplasms - mortality | Aged, 80 and over | Adult | Female | Pyridines - therapeutic use | Skin Neoplasms - pathology | Drug Administration Schedule | Risk Assessment | Administration, Oral | Patient Safety - statistics & numerical data | Treatment Outcome | Carcinoma, Basal Cell - pathology | Maximum Tolerated Dose | Survival Analysis | Carcinoma, Basal Cell - drug therapy | Aged | Neoplasm Staging | Analysis | Basal cell carcinoma
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial
by Basset-Séguin, N and Hauschild, A and Kunstfeld, R and Grob, J and Dréno, B and Mortier, L and Ascierto, P.A and Licitra, L and Dutriaux, C and Thomas, L and Meyer, N and Guillot, B and Dummer, R and Arenberger, P and Fife, K and Raimundo, A and Dika, E and Dimier, N and Fittipaldo, A and Xynos, I and Hansson, J
European Journal of Cancer, ISSN 0959-8049, 11/2017, Volume 86, pp. 334 - 348
The SafeTy Events in VIsmodEgib study (STEVIE, ClinicalTrials.gov, ), assessed safety and efficacy of vismodegib—a first-in-class Hedgehog pathway inhibitor... 
Basal cell carcinoma | Vismodegib | Gorlin syndrome | STEVIE | Hedgehog pathway inhibitor | MANAGEMENT | EFFICACY | ONCOLOGY | SAFETY | RISK | ADVERSE EVENTS | Basal Cell Nevus Syndrome - mortality | Anilides - adverse effects | Humans | Middle Aged | Carcinoma, Basal Cell - secondary | Male | Antineoplastic Agents - administration & dosage | Spasm - chemically induced | Young Adult | Basal Cell Nevus Syndrome - pathology | Carcinoma, Basal Cell - mortality | Pyridines - adverse effects | Time Factors | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Pyridines - administration & dosage | Creatine Kinase - blood | Drug Administration Schedule | Administration, Oral | Kaplan-Meier Estimate | Treatment Outcome | Disease Progression | Disease-Free Survival | Anilides - administration & dosage | Adolescent | Carcinoma, Basal Cell - drug therapy | Aged | Basal Cell Nevus Syndrome - drug therapy | Care and treatment | Analysis | Life Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Screening for Skin Cancer: US Preventive Services Task Force Recommendation Statement
by Bibbins-Domingo, Kirsten and Grossman, David C and Curry, Susan J and Davidson, Karina W and Ebell, Mark and Epling, John W and García, Francisco A. R and Gillman, Matthew W and Kemper, Alex R and Krist, Alex H and Kurth, Ann E and Landefeld, C. Seth and Mangione, Carol M and Phillips, William R and Phipps, Maureen G and Pignone, Michael P and Siu, Albert L and US Preventive Serv Task Force and US Preventive Services Task Force
JAMA, ISSN 0098-7484, 07/2016, Volume 316, Issue 4, pp. 429 - 435
IMPORTANCE: Basal and squamous cell carcinoma are the most common types of cancer in the United States and represent the vast majority of all cases of skin... 
DERMATOLOGISTS | MEDICINE, GENERAL & INTERNAL | MELANOMA | PROGRAM | Melanoma - diagnosis | Physical Examination - methods | Early Detection of Cancer - methods | Humans | Middle Aged | Male | Advisory Committees | Carcinoma, Basal Cell - diagnosis | Carcinoma, Squamous Cell - diagnosis | Carcinoma, Basal Cell - mortality | Carcinoma, Squamous Cell - mortality | Skin Neoplasms - prevention & control | Melanoma - prevention & control | Skin Neoplasms - mortality | Skin Neoplasms - diagnosis | Carcinoma, Basal Cell - prevention & control | Adult | Female | Physical Examination - standards | Early Detection of Cancer - standards | Dermatology | Early Detection of Cancer - mortality | Carcinoma, Squamous Cell - prevention & control | Aged | Primary Health Care | Melanoma - mortality | Usage | Care and treatment | Skin | Medical examination | Medical screening | Skin cancer | Mortality | Melanoma
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text All-cause mortality in patients with basal and squamous cell carcinoma: A systematic review and meta-analysis
by Wehner, Mackenzie R and Cidre Serrano, Wilmarie and Nosrati, Adi and Schoen, Patrick Michael and Chren, Mary-Margaret and Boscardin, John and Linos, Eleni
Journal of the American Academy of Dermatology, ISSN 0190-9622, 04/2018, Volume 78, Issue 4, pp. 663 - 672.e3
There are varying reports of the association of basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (SCC) with mortality. To synthesize the... 
meta-analysis | basal cell carcinoma | cutaneous squamous cell carcinoma | systematic review | all-cause mortality | keratinocyte carcinoma | LEUKOCYTE TELOMERE LENGTH | UNITED-STATES | SURVIVAL | POPULATION | DNA-DAMAGE | RISK | 10-YEAR MORTALITY | DERMATOLOGY | NONMELANOMA SKIN-CANCER | POOR-PROGNOSIS | COHORT | Carcinoma, Basal Cell - mortality | Carcinoma, Squamous Cell - mortality | Skin Neoplasms - mortality | Humans | Cause of Death | Basal cell carcinoma
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Chemoprevention of basal and squamous cell carcinoma with a single course of fluorouracil, 5%, cream: A randomized clinical trial
by Weinstock, Martin A and Thwin, Soe Soe and Siegel, Julia A and Marcolivio, Kimberly and Means, Alexander D and Leader, Nicholas F and Shaw, Fiona M and Hogan, Daniel and Eilers, David and Swetter, Susan M and Chen, Suephy C and Jacob, Sharon E and Warshaw, Erin M and Stricklin, George P and Dellavalle, Robert P and Sidhu-Malik, Navjeet and Konnikov, Nellie and Werth, Victoria P and Keri, Jonette E and Robinson-Bostom, Leslie and Ringer, Robert J and Lew, Robert A and Ferguson, Ryan and DiGiovanna, John J and Huang, Grant D and Veterans Affairs Keratinocyte Carc and Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial (VAKCC) Group and for the Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial (VAKCC) Group
JAMA Dermatology, ISSN 2168-6068, 02/2018, Volume 154, Issue 2, pp. 167 - 174
IMPORTANCE Keratinocyte carcinoma (ie, cutaneous basal and squamous cell carcinoma) is the most common cancer in the United States. OBJECTIVE To determine... 
5-FLUOROURACIL | MULTIPLE KERATINOCYTE CARCINOMAS | NONMELANOMA SKIN-CANCER | EFFICACY | NICOTINAMIDE | PREDICTORS | ACTINIC KERATOSIS TREATMENT | PREVENTION | VALIDATION | TOXICITY | DERMATOLOGY | Prognosis | Skin Neoplasms - drug therapy | Humans | Middle Aged | Carcinoma, Squamous Cell - surgery | Male | Administration, Cutaneous | Dose-Response Relationship, Drug | Carcinoma, Basal Cell - mortality | Carcinoma, Squamous Cell - mortality | Fluorouracil - administration & dosage | Skin Neoplasms - prevention & control | Mohs Surgery - methods | Skin Neoplasms - mortality | Aged, 80 and over | Carcinoma, Basal Cell - prevention & control | Skin Cream - therapeutic use | Adult | Female | Skin Neoplasms - surgery | Double-Blind Method | Drug Administration Schedule | Risk Assessment | Treatment Outcome | Carcinoma, Squamous Cell - prevention & control | Carcinoma, Basal Cell - surgery | Carcinoma, Squamous Cell - drug therapy | Mohs Surgery - statistics & numerical data | Survival Analysis | Carcinoma, Basal Cell - drug therapy | Aged | Chemoprevention - methods | Online First | Original Investigation | Research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Survival after squamous cell and basal cell carcinoma of the skin: A retrospective cohort analysis
by Rees, Judy R and Zens, M. Scot and Celaya, Maria O and Riddle, Bruce L and Karagas, Margaret R and Peacock, Janet L
International Journal of Cancer, ISSN 0020-7136, 08/2015, Volume 137, Issue 4, pp. 878 - 884
A retrospective cohort analysis of survival after keratinocyte cancer (KC) was conducted using data from a large, population‐based case–control study of KC in... 
basal cell carcinoma | survival | squamous cell carcinoma | UNITED-STATES | DIAGNOSIS | 2ND PRIMARY CANCERS | SUBSEQUENT CANCER | RISK | 10-YEAR MORTALITY | ONCOLOGY | POOR-PROGNOSIS | POPULATION-BASED COHORT | PRIMARY MALIGNANCY | PATIENT SURVIVAL | Skin Neoplasms - pathology | Carcinoma, Basal Cell - mortality | Carcinoma, Squamous Cell - mortality | Follow-Up Studies | Skin Neoplasms - mortality | Carcinoma, Squamous Cell - pathology | Humans | Survival Analysis | Female | Male | Carcinoma, Basal Cell - pathology | Neoplasm Staging | Squamous cell carcinoma | Skin | Basal cell carcinoma | Analysis | Mortality | Melanoma | Confidence intervals | Health risk assessment | Skin cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Basal cell carcinoma with matrical differentiation: Clinicopathologic, immunohistochemical, and molecular biological study of 22 cases
by Kyrpychova, Liubov and Carr, Richard A and Martinek, Petr and Vanecek, Tomas and Perret, Raul and Chottová-Dvořáková, Magdalena and Zamecnik, Michal and Hadravsky, Ladislav and Michal, Michal and Kazakov, Dmitry V
American Journal of Surgical Pathology, ISSN 0147-5185, 05/2017, Volume 41, Issue 6, pp. 738 - 749
Basal cell carcinoma (BCC) with matrical differentiation is a fairly rare neoplasm, with about 30 cases documented mainly as isolated case reports. We studied... 
β-catenin | Basal cell carcinoma | CDKN2A | ERBB4 | Matrical | CTNNB1 | PTCH | Pilomatrical carcinoma | beta-catenin | BETA-CATENIN GENE | SURGERY | MULTIPLE FAMILIAL TRICHOEPITHELIOMAS | APOCRINE POROMA | pilomatrical carcinoma | PATHOLOGY | matrical | PILOMATRIX CARCINOMA | MICROCYSTIC ADNEXAL CARCINOMA | SEBACEOUS DIFFERENTIATION | basal cell carcinoma | FOLLICULAR DIFFERENTIATION | BROOKE-SPIEGLER-SYNDROME | HUMAN HOMOLOG | ACTIVATING MUTATIONS | Hair Diseases - pathology | Immunohistochemistry | Hair Diseases - genetics | Prognosis | Carcinoma, Basal Cell - genetics | Follow-Up Studies | Humans | Middle Aged | Male | Hair Diseases - mortality | Carcinoma, Basal Cell - mortality | Pilomatrixoma - mortality | Hair Diseases - metabolism | Skin Neoplasms - mortality | Pilomatrixoma - genetics | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | Cell Differentiation | Skin Neoplasms - pathology | Carcinoma, Basal Cell - pathology | Pilomatrixoma - pathology | Carcinoma, Basal Cell - metabolism | Skin Neoplasms - metabolism | Skin Neoplasms - genetics | Aged | Biomarkers, Tumor - genetics | High-Throughput Nucleotide Sequencing | Pilomatrixoma - metabolism | Mutation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text The Epidemiology and Clinicopathological Features of Basal Cell Carcinoma in Patients 80 Years and Older: A Systematic Review
by Lubeek, Satish F. K and van Vugt, Lieke J and Aben, Katja K. H and van de Kerkhof, Peter C. M and Gerritsen, Marie-Jeanne P
JAMA Dermatology, ISSN 2168-6068, 01/2017, Volume 153, Issue 1, pp. 71 - 78
IMPORTANCE: The number of very elderly (≥80 years) is rapidly growing worldwide. Basal cell carcinoma (BCC) are common in this age group and treatment is often... 
POPULATION-BASED INCIDENCE | MORTALITY | INVASION | MELANOMA | NONMELANOMA SKIN-CANCER | GIANT BASAL | DESCRIPTIVE EPIDEMIOLOGY | RISK | OF-THE-LITERATURE | TRENDS | DERMATOLOGY | Skin Neoplasms - pathology | Prevalence | Age Factors | Humans | Carcinoma, Basal Cell - secondary | Carcinoma, Basal Cell - epidemiology | Tumor Burden | Skin Neoplasms - epidemiology | Incidence | Carcinoma, Basal Cell - mortality | Skin Neoplasms - mortality | Sex Factors | Aged, 80 and over | Care and treatment | Aged | Basal cell carcinoma | Research | Epidemiology | Health aspects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation
by Rakha, EA and Putti, TC and Abd El‐Rehim, DM and Paish, C and Green, AR and Powe, DG and Lee, AH and Robertson, JF and Ellis, IO
The Journal of Pathology, ISSN 0022-3417, 03/2006, Volume 208, Issue 4, pp. 495 - 506
The aim of this study was to assess the morphological characteristics and immunohistochemical profile of breast carcinomas with basal and myoepithelial... 
myoepithelial | morphology | breast carcinoma | basal | immunoprofile | Basal | Myoepithelial | Breast Carcinoma | Immunoprofile | Morphology | SMOOTH MUSCLE ACTIN | TISSUE MICROARRAY TECHNOLOGY | DIAGNOSIS | PATHOLOGY | CANCER | ONCOLOGY | BENIGN | TERM FOLLOW-UP | PATHOLOGICAL PROGNOSTIC FACTORS | CELL-DIFFERENTIATION | EXPRESSION | DUCTAL CARCINOMA | Immunohistochemistry | Multivariate Analysis | Myoepithelioma - metabolism | Myoepithelioma - mortality | Age Factors | Humans | Middle Aged | Carcinoma, Ductal, Breast - mortality | Myoepithelioma - pathology | Actins - genetics | Breast Neoplasms - metabolism | Necrosis | Genes, p53 | Receptors, Androgen - analysis | Adult | Carcinoma, Ductal, Breast - pathology | Female | Cell Differentiation | Carcinoma, Ductal, Breast - metabolism | Biomarkers, Tumor - analysis | Cadherins - analysis | Survival Rate | Receptor, Epidermal Growth Factor - analysis | Neoplasms, Basal Cell - pathology | Disease-Free Survival | Breast Neoplasms - pathology | Staining and Labeling | Neoplasms, Basal Cell - immunology | Breast Neoplasms - mortality | Aged | Keratins - genetics | Neoplasms, Basal Cell - mortality
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Screening for Skin Cancer in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
by Wernli, Karen J and Henrikson, Nora B and Morrison, Caitlin C and Nguyen, Matthew and Pocobelli, Gaia and Blasi, Paula R
JAMA, ISSN 0098-7484, 07/2016, Volume 316, Issue 4, pp. 436 - 447
IMPORTANCE: Skin cancer, primarily melanoma, is a leading cause of morbidity and mortality in the United States. OBJECTIVE: To provide an updated systematic... 
UNITED-STATES | SURVIVAL | MEDICINE, GENERAL & INTERNAL | INVASIVE CUTANEOUS MELANOMA | OLDER PATIENTS | BIOPSY | RISK | THIN MELANOMAS | OVERDIAGNOSIS | OUTCOMES | SOCIOECONOMIC-STATUS | Melanoma - epidemiology | Melanoma - diagnosis | Physical Examination - methods | United States | Humans | Middle Aged | Male | Carcinoma, Basal Cell - epidemiology | Primary Health Care - standards | Advisory Committees | Carcinoma, Basal Cell - diagnosis | Carcinoma, Squamous Cell - diagnosis | Young Adult | Carcinoma, Basal Cell - mortality | Carcinoma, Squamous Cell - mortality | Skin Neoplasms - prevention & control | Melanoma - prevention & control | Early Detection of Cancer - adverse effects | Skin Neoplasms - mortality | Sensitivity and Specificity | Skin Neoplasms - diagnosis | Preventive Health Services | Adult | Female | Dermatology - standards | Carcinoma, Squamous Cell - epidemiology | Tumor Burden | Evidence-Based Medicine | Skin Neoplasms - epidemiology | Adolescent | Aged | Melanoma - mortality | Usage | Medical examination | Adults | Management | Medical screening | Health aspects | Evidence-based medicine | Skin cancer | Systematic review | Mortality | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Comorbidity scores associated with limited life expectancy in the very elderly with nonmelanoma skin cancer
by Rogers, Emma M and Connolly, Karen L and Nehal, Kishwer S and Dusza, Stephen W and Rossi, Anthony M and Lee, Erica
Journal of the American Academy of Dermatology, ISSN 0190-9622, 06/2018, Volume 78, Issue 6, pp. 1119 - 1124
There is controversy regarding treatment of nonmelanoma skin cancer (NMSC) in very elderly individuals, with some suggesting that this population may not live... 
Mohs micrographic surgery | skin cancer | comorbidity | limited life expectancy | NMSC | elderly | MORTALITY | POPULATION | AGED 90 YEARS | OLDER | FUNCTIONAL STATUS | DERMATOLOGY | BASAL-CELL CARCINOMA | INDEXES | Geriatric Assessment | Skin Neoplasms - pathology | Risk Assessment | Comorbidity | Carcinoma, Squamous Cell - pathology | Humans | Carcinoma, Squamous Cell - surgery | Male | Carcinoma, Basal Cell - pathology | Mohs Surgery - mortality | Carcinoma, Basal Cell - mortality | Carcinoma, Basal Cell - surgery | Carcinoma, Squamous Cell - mortality | Time Factors | Life Expectancy | Mohs Surgery - methods | Skin Neoplasms - mortality | Sex Factors | Survival Analysis | Aged, 80 and over | Female | Retrospective Studies | Skin Neoplasms - surgery | Cohort Studies | Medical research | Life expectancy | Dermatology | Melanoma | Formulae, receipts, prescriptions | Medicine, Experimental | Dermatologic agents | Aged | Health aspects | Skin cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights